DE69122298T2 - Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung - Google Patents

Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung

Info

Publication number
DE69122298T2
DE69122298T2 DE69122298T DE69122298T DE69122298T2 DE 69122298 T2 DE69122298 T2 DE 69122298T2 DE 69122298 T DE69122298 T DE 69122298T DE 69122298 T DE69122298 T DE 69122298T DE 69122298 T2 DE69122298 T2 DE 69122298T2
Authority
DE
Germany
Prior art keywords
pseudomembrane
treatment
clostridium difficile
colon inflammation
difficile diarrhea
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69122298T
Other languages
English (en)
Other versions
DE69122298D1 (de
Inventor
Itsuki Fujita
Nobuhiro Taguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
MIYARISAN SEIBUTSU IGAKU KENKY
Original Assignee
MIYARISAN SEIBUTSU IGAKU KENKY
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MIYARISAN SEIBUTSU IGAKU KENKY filed Critical MIYARISAN SEIBUTSU IGAKU KENKY
Application granted granted Critical
Publication of DE69122298D1 publication Critical patent/DE69122298D1/de
Publication of DE69122298T2 publication Critical patent/DE69122298T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/08—Clostridium, e.g. Clostridium tetani
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14—Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE69122298T 1990-05-07 1991-05-02 Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung Expired - Fee Related DE69122298T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2117267A JP2961184B2 (ja) 1990-05-07 1990-05-07 クロストリジウム・ディフィシル下痢症および偽膜性大腸炎の予防ならびに治療用医薬組成物

Publications (2)

Publication Number Publication Date
DE69122298D1 DE69122298D1 (de) 1996-10-31
DE69122298T2 true DE69122298T2 (de) 1997-02-06

Family

ID=14707530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69122298T Expired - Fee Related DE69122298T2 (de) 1990-05-07 1991-05-02 Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung

Country Status (6)

Country Link
EP (1) EP0456418B1 (de)
JP (1) JP2961184B2 (de)
KR (1) KR0149672B1 (de)
DE (1) DE69122298T2 (de)
ES (1) ES2091290T3 (de)
HU (1) HUT61464A (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5301399A (en) * 1998-08-20 2000-03-14 Miyarisan Pharmaceutical Co.,Ltd. Rugs comprising butyric acid-producing bacterium combined with bile acid component
WO2000027509A1 (fr) 1998-11-09 2000-05-18 Nippon Sanso Corporation Procede et dispositif d'enrichissement en composant lourd d'isotopes d'oxygene
AUPQ899700A0 (en) 2000-07-25 2000-08-17 Borody, Thomas Julius Probiotic recolonisation therapy
EP1389464A4 (de) * 2001-04-06 2005-06-22 Combi Co Zusammensetzungen mit einem bakterium, das milchsäure in buttersäure umwandeln kann, und verfahren zur prävention/behandlung von hyperlaktacidämie bei karzinomen in verdauungstrakt und kolon unter verwendung dieser zusammensetzungen
EP2195004B1 (de) * 2007-09-12 2015-04-01 The Medicines Company Verfahren zur unterdrückung von clostridium difficile durch verabreichung von oritavancin
EP2600877A4 (de) 2010-08-04 2014-05-07 Borody Thomas J Zusammensetzungen zur darmflora-transplantation und verfahren zu ihrer herstellung und verwendung sowie verfahren zu ihrer verabreichung
JP2014507481A (ja) 2011-03-09 2014-03-27 リージェンツ オブ ザ ユニバーシティ オブ ミネソタ 結腸微生物相移植のための組成物及び方法
EP2836224A4 (de) 2012-02-29 2015-12-16 Ethicon Endo Surgery Inc Zusammensetzungen von biozönose und zugehörige verfahren
WO2013176774A1 (en) 2012-05-25 2013-11-28 Arizona Board Of Regents Microbiome markers and therapies for autism spectrum disorders
US8906668B2 (en) 2012-11-23 2014-12-09 Seres Health, Inc. Synergistic bacterial compositions and methods of production and use thereof
SG10201704035TA (en) * 2012-11-23 2017-06-29 Seres Therapeutics Inc Synergistic bacterial compositions and methods of production and use thereof
EP2951285A4 (de) 2013-02-04 2016-10-26 Seres Therapeutics Inc Zusammensetzungen und verfahren zur hemmung des wachstums pathogener bakterien
US10973861B2 (en) 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
EP2967077A4 (de) 2013-03-15 2016-09-14 Seres Therapeutics Inc Netzwerkbasierte mikrobielle zusammensetzungen und verfahren
AU2014352643A1 (en) 2013-11-25 2016-06-30 Seres Therapeutics, Inc. Synergistic bacterial compositions and methods of production and use thereof
US9956282B2 (en) 2013-12-16 2018-05-01 Seres Therapeutics, Inc. Bacterial compositions and methods of use thereof for treatment of immune system disorders
GB2551642B (en) 2014-10-31 2020-09-23 Pendulum Therapeutics Inc Methods and compositions relating to microbial treatment and diagnosis of disorders
KR102561989B1 (ko) 2015-05-14 2023-07-31 핀치 테라퓨틱스 홀딩스 엘엘씨 대변 균무리 이식용 조성물, 및 이의 제조 및 사용 방법, 및 이의 전달을 위한 장치
AU2016268158B2 (en) 2015-05-22 2022-03-17 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
WO2017033925A1 (ja) * 2015-08-24 2017-03-02 株式会社ヤクルト本社 酪酸産生菌
US20170360848A1 (en) 2016-06-15 2017-12-21 Arizona Board Of Regents On Behalf Of Arizona State University Methods for treating autism spectrum disorder and associated symptoms
US10849936B2 (en) 2016-07-01 2020-12-01 Regents Of The University Of Minnesota Compositions and methods for C. difficile treatment
US20180036352A1 (en) 2016-08-03 2018-02-08 Crestovo Holdings Llc Methods for treating ulcerative colitis
WO2018071536A1 (en) 2016-10-11 2018-04-19 Crestovo Holdings Llc Compositions and methods for treating primary sclerosing cholangitis and related disorders
US11026978B2 (en) 2016-10-11 2021-06-08 Finch Therapeutics Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US10092601B2 (en) 2016-10-11 2018-10-09 Crestovo Holdings Llc Compositions and methods for treating multiple sclerosis and related disorders
US11040073B2 (en) 2017-04-05 2021-06-22 Finch Therapeutics Holdings Llc Compositions and methods for treating diverticulitis and related disorders
CN110831606A (zh) 2017-04-05 2020-02-21 克雷斯顿沃控股公司 治疗帕金森氏病(pd)和相关疾病的组合物和方法
EP3630190B1 (de) 2017-05-26 2024-02-21 Finch Therapeutics Holdings LLC Lyophilisierte zusammensetzungen, die therapeutische mittel auf der basis von fäkalienmikroben enthalten, und verfahren zu ihrer herstellung und verwendung
US11865145B2 (en) 2017-08-07 2024-01-09 Finch Therapeutics Holdings Llc Compositions and methods for maintaining and restoring a healthy gut barrier
RU2020110462A (ru) 2017-08-14 2021-09-16 Серес Терапеутикс, Инк. Композиции и способы для лечения холестатического заболевания
WO2019046646A1 (en) 2017-08-30 2019-03-07 Whole Biome Inc. METHODS AND COMPOSITIONS FOR THE TREATMENT OF MICROBIOMA ASSOCIATED DISORDERS
CN107937305B (zh) * 2017-11-21 2021-04-23 湖北绿雪生物科技有限公司 一株耐丁酸、抗逆性强的丁酸梭菌菌剂及其应用
US11166990B2 (en) 2018-07-13 2021-11-09 Finch Therapeutics Holdings Llc Methods and compositions for treating ulcerative colitis
US11911419B2 (en) 2018-09-27 2024-02-27 Finch Therapeutics Holdings Llc Compositions and methods for treating epilepsy and related disorders

Also Published As

Publication number Publication date
ES2091290T3 (es) 1996-11-01
HU911188D0 (en) 1991-10-28
JP2961184B2 (ja) 1999-10-12
KR910019640A (ko) 1991-12-19
EP0456418B1 (de) 1996-09-25
EP0456418A2 (de) 1991-11-13
JPH0413628A (ja) 1992-01-17
KR0149672B1 (ko) 1998-10-15
DE69122298D1 (de) 1996-10-31
EP0456418A3 (en) 1993-01-20
HUT61464A (en) 1993-01-28

Similar Documents

Publication Publication Date Title
DE69122298D1 (de) Behandlung von Clostridium difficile Diarrhöe und pseudomembraner Dickdarmentzündung
DE69220679T2 (de) Antibakterielles mittel und behandlung von gegenständen mit diesem
DE69530597T2 (de) Behandlung von Obst und Gemüse
DE69329848T2 (de) Poymerisationsverfahren und daraus hergestellte tonerzusammensetzungen
DE69014030T3 (de) Mittel für die Verhütung und Behandlung von Diarrhöe.
DE69530860D1 (de) Behandlung der entzündung des sehnervs
ATA209789A (de) Behandlung von zementpulver
DE69430903T2 (de) Behandlung von periodontitis mit misoprostol
DE69429160D1 (de) Behandlung von textilprodukt
DE69100314D1 (de) Behandlung von Clostridium difficile Diarrhöe und Pseudomembrankolitis.
DE69405711D1 (de) Behandlung von rueckstandsoel
DE69303930T2 (de) Behandlung von mit quecksilber verunreinigtem schlamm
DE69132054D1 (de) Behandlung von windelausschlag
DE69306335T2 (de) Prevention und Behandlung von Atherosclerosis
DE68923219T2 (de) Behandlung von Abfällen.
DE69520268D1 (de) Behandlung von Legierungen und danach hergestellte Gegenstände
NO913661D0 (no) Anordning og fremgangsmaate for dosering av vaskemiddelkompositter.
DE69429259D1 (de) Behandlung von futtern und fasergut
DE69124686D1 (de) Wärmebehandlung von Halbleiterbauelementen
DE69120915D1 (de) Behandlung von Polyarylensulfidharzen
NO931904D0 (no) Anordning for mottak av tomflasker og tilbakebetaling av pant
DE69023632D1 (de) Detektion und Reduktion von Störungen.
DE3881377D1 (de) Mittel zur prophylaxe und behandlung von thrombocytopenie.
DE69717906T2 (de) Behandlung von Schistosomiasis
DE69117566T2 (de) Verwendung von Isomonoolen zur Behandlung und Prophylaxe von Krebserkrankungen

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee